ZNN Bactiguard Retrograde Femoral Nails PMCF Study
Post-Market Clinical Follow-up Study on the ZNN™ Bactiguard ® Retrograde Femoral Nails (Implants and Instrumentation)
Sponsor: Zimmer Biomet
A observational or N/A phase clinical study on Femoral Fracture, this trial is actively recruiting participants. The trial is conducted by Zimmer Biomet and has accumulated 10 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Sep 2025 — Feb 2026 [monthly]
Recruiting
-
Jan 2025 — Sep 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jul 2023 — Jul 2024 [monthly]
Not Yet Recruiting
-
Feb 2023 — Jul 2023 [monthly]
Not Yet Recruiting
-
Nov 2022 — Feb 2023 [monthly]
Not Yet Recruiting
-
Apr 2022 — Nov 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Biomet
For direct contact, visit the study record on ClinicalTrials.gov .